13D/13G Filings - Atlas Venture Fund VII L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-06-14
4:15 pm
Unchanged
2023-05-23 13D Viridian Therapeutics, Inc.
VRDN
Atlas Venture Fund VII L P 0
0.000%
0
(Unchanged)
Filing
History
2021-02-03
5:20 pm
Purchase
2020-11-20 13G F-star Therapeutics, Inc.
FSTX
Atlas Venture Fund VII L P 574,996
6.300%
574,996increase
(New Position)
Filing
History
2021-02-02
1:04 pm
Purchase
2020-12-31 13G Larimar Therapeutics, Inc.
LRMR
Atlas Venture Fund VII L P 292,182
1.900%
292,182increase
(New Position)
Filing
History